Philippine Health Research Registry
Display Options
Results List
Results 1 - 6 of 6 research(es) under NUHRA Regime 2017 - 2022, Global competitiveness and innovation in health, Drug discovery and development

Show: All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

#
Study
         
Project Status:
Ongoing
Project Description:
This study uses a randomized, multicenter, double-blind, placebo-controlled parallel-group study design in which QAW039 or placebo is added to incoming SoC asthma therapy (Figure 3-1).  Asthma patients who are already receiving ICS or ICS with one asthma controller medication (see inclusion criterion 4 for allowed ICS doses and combinations) are t... [read more]
Project Status:
Ongoing
Project Description:
This study uses a single-cohort, 3-treatment arm, randomized (2:3:3 [140 mg: 70 mg: placebo]), double-blind study design in adult patients with episodic migraine. . A screening period of 2 weeks will be used to assess initial eligibility, followed by a 4-week baseline period (the maximum duration for the baseline period is 35 days), during which di... [read more]
Project Status:
Ongoing
Project Description:
This is a randomized, double-blind, placebo-controlled, 2-arm, parallel-group, multicenter study. Subjects with T2DM >=10 and =6.5% to <=10.5%) and who meet 1 of the criteria below will be eligible to be screened: 1.  Are on diet and exercise for at least 8 weeks prior to screening or 2. Are on diet and exercise and a stable dose of metformi... [read more]
Project Status:
Ongoing
Project Description:
SHP640-301 is a phase III, global, multi-center, randomized, double-masked, parallel group, placebo controlled study designed to demonstrate the safety and efficacy of SHP640 ophthalmic suspension compared to PVP-I 0.6% ophthalmic solution and to placebo in treating adenoviral conjunctivitis.   SHP640, a novel topical ophthalmic suspension, is cur... [read more]
Project Status:
Ongoing
Project Description:
SHP640-303 is a phase III, global, multicenter, randomized, double-masked, parallel-group, placebocontrolled study designed to demonstrate the safety and efficacy of SHP640 ophthalmic suspension compared to placebo in treating bacterial conjunctivitis. In addition, an exploratory arm of PVP-I 0.6% ophthalmic solution will be included. SHP640, a nov... [read more]
Project Status:
Pending
Project Description:
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center, international study assessing the efficacy and safety of durvalumab given concurrently with platinum-based CRT (durvalumab + standard of care [SoC] CRT) in patients with locally advanced, unresectable NSCLC (Stage III). Approximately 390 patients with locally advanced... [read more]